Landscapes / Targets

IL-12

14 drugs act on IL-12, in 22 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs14

DrugHow it worksCompanyStageNext dateDetails
Monoclonal antibody
Approved 29 Sep 2027Phase 3 trial completes
—
Phase 1/2 30 Dec 2026Phase 1/2 trial completes
—
Akeso · Public 9926.HK
Phase 2 28 Feb 2027Phase 1/2 trial completes
—
Phase 1/2 May 2027Phase 1/2 trial completes
INO-3112not checked
—
Phase 1/2 31 Dec 2027Phase 1/2 trial completes
—
Phase 1/2 Sep 2028Phase 1/2 trial completes
—
Phase 1/2 2 Dec 2028Phase 1/2 trial completes
—
Phase 2 Sep 2029Phase 2 trial completes
—
Phase 1/2 17 Jul 2030Phase 1/2 trial completes
—
Phase 2 —
—
Phase 1 Dec 2026Phase 1 trial completes
—
Phase 1 1 Jan 2027Phase 1 trial completes
—
Phase 1 30 Dec 2027Phase 1 trial completes
—
Phase 1 —

About this list

Checked
13 of 14 drugs. The other 1 is marked “not checked” in the list. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow IL-12

Following is part of Solo: you see every change to IL-12 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in